The brain fog and stress sensitivity that showed up in perimenopause felt like a personality change, not a symptom. Learning that something as structural as a cell membrane component could influence both memory and the cortisol spiral was genuinely surprising — and made the exhaustion feel a lot less like a personal failing.
Learn more about Rose →Phosphatidylserine (PS) is a phospholipid — a fat-based molecule — that sits primarily on the inner leaflet of neuronal cell membranes, where it helps regulate membrane fluidity, cell signalling, and the activity of ion pumps. It makes up roughly 15% of the total phospholipid content in the brain, a higher concentration than in most other tissues. When membrane integrity is compromised, neuronal communication slows, which is one reason PS has been studied in the context of age-related cognitive decline.
The body synthesises phosphatidylserine primarily through a process called PS synthase, but endogenous production decreases with age, and dietary intake rarely compensates fully. Estrogen has been shown to support the activity of enzymes involved in phospholipid metabolism, meaning the hormonal shift of perimenopause may compound the age-related decline in PS availability. This overlap in timing — hormonal change meeting declining PS synthesis — may partly explain why cognitive symptoms often feel disproportionately sharp in the perimenopausal window rather than later in postmenopause.
Multiple randomised controlled trials have shown that supplemental phosphatidylserine significantly reduces cortisol and ACTH secretion in response to physical and psychological stress. One well-cited study found that 800mg of PS daily reduced cortisol response to exercise stress by approximately 30%. This is clinically relevant in perimenopause because dysregulated cortisol is already common as the HPA axis becomes more reactive when ovarian hormone levels fluctuate.
Elevated evening cortisol is one of the more underappreciated drivers of perimenopausal sleep disruption — it delays sleep onset and reduces slow-wave sleep independently of hot flushes. By moderating the overall cortisol load, phosphatidylserine may help shift the cortisol curve back toward its natural morning peak, making it easier for the body to wind down at night. The evidence here is indirect rather than from direct sleep-outcome trials, but the mechanistic logic is sound.
Phosphatidylserine influences the function of acetylcholine-releasing neurons (cholinergic neurons), which are central to encoding and retrieving short-term memories. Research in older adults with age-associated memory impairment found that PS supplementation improved memory test scores and word recall compared to placebo. This mechanism is worth understanding because the word-retrieval and name-forgetting symptoms women commonly report in perimenopause are consistent with reduced cholinergic efficiency.
In 2003, the US Food and Drug Administration issued qualified health claims stating that PS may reduce the risk of cognitive dysfunction and dementia in older adults, while noting that the evidence was limited and not conclusive. This is a relatively rare status for a nutritional supplement and reflects the volume of peer-reviewed data accumulated over the preceding two decades. It does not mean PS is a treatment for dementia, but it does signal that the cognitive research is substantial enough to have cleared regulatory scrutiny.
Early clinical trials in the 1980s and 1990s used bovine cortex-derived PS, which raised theoretical concerns about prion disease transmission as well as practical sourcing issues. The PS in supplements today is almost universally derived from soy lecithin (soy-PS) or sunflower lecithin, which eliminates those concerns. It is worth noting that soy-PS has a slightly different fatty acid profile than bovine-PS, and some researchers argue the cognitive trial data from bovine preparations may not fully transfer — though soy-PS trials have shown consistent effects.
Studies showing cognitive benefits have most commonly used 300mg per day, often divided into three 100mg doses taken with meals to improve absorption, since PS is fat-soluble. Cortisol-blunting studies have tended to use higher doses of 600–800mg, typically in athletic or acute-stress contexts. There is no established therapeutic dose for perimenopausal use specifically, and starting at the lower end of the studied range is a sensible approach before adjusting.
Phosphatidylserine has a strong safety record in human trials, with GI discomfort being the most commonly reported side effect and typically mild. The interaction worth knowing: because PS may have mild anticoagulant properties, caution is warranted for anyone taking blood-thinning medications such as warfarin or aspirin at therapeutic doses — the combination could theoretically increase bleeding risk. Women considering PS alongside any prescription medication should loop in their prescriber before starting.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.